LINICAL EFFICACY/EFFECTIVENESS OF COMBINED THERAPY WITH INTERFERON (PEGYLATED OR NON-PEGYLATED) plus RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Almadiyeva, A. [1 ]
Kostyuk, A. [1 ]
机构：
[1] Natl Ctr Hlth Dev, Astana, Kazakhstan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.372
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [21] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [22] The Association of Leptin Reduction With Efficacy of Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C
    Kaneko, Fumihiko
    Yokomori, Hiroaki
    Kumagai, Naoki
    Toda, Kyoko
    Tsunematsu, Satoshi
    Tsuchimoto, Kanji
    Saito, Hidetsugu
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2010, 138 (05) : S842 - S842
  • [23] Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis
    Hartwell, Debbie
    Shepherd, Jonathan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (01) : 56 - 62
  • [24] Impact of Ribavirin Dosage in Chronic Hepatitis C Patients Treated With Simeprevir, Pegylated Interferon Plus Ribavirin Combination Therapy
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Hosui, Atsushi
    Oshita, Masahide
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Yamada, Yukinori
    Inada, Masami
    Katayama, Kazuhiro
    Tamura, Shinji
    Imai, Yasuharu
    Hikita, Hayato
    Sakamori, Ryotaro
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (10) : 1776 - 1784
  • [25] Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy
    Hamza, Iman
    Eid, Yara
    El-Sayed, Mohammad
    Marzaban, Raghda
    Abdul-Kareem, Shaimaa
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (09): : 527 - 533
  • [26] Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
    Huang, Ching-I
    Huang, Chung-Feng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Yeh, Ming-Lun
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1012 - 1018
  • [27] EFFICACY AND SAFETY OF PEGYLATED INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS
    Dai, C. -Y.
    Huang, C. -F.
    Yu, M. -L
    Huang, J-F
    Chuang, W-L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227
  • [28] The efficacy of pegylated interferon plus ribavirin combination therapy in chronic hepatitis C patients with hepatocellular carcinoma post curative therapies
    Huang, J-F
    Yu, M-L
    Dai, C-Y
    Hou, N-J
    Huang, C-F
    Chiu, C-F
    Huang, C-I
    Yeh, M-L
    Hsieh, M-H
    Yang, J-F
    Lin, Z-Y
    Chen, S-C
    Chuang, W-L
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A156 - A156
  • [29] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [30] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
12345